Nature Communications

TG4050

TG4050 as a single agent has the potential to prevent recurrence in head and neck cancer

 

Peer-reviewed publication in Nature Communications highlights the Phase 1 clinical and translational findings

 

Article available for the first time on Nature Communications website – Download the Article